Pharmacodynamics of L-NMMA in type 1 diabetes patients and control subjects

Journal of Cardiovascular Pharmacology

Volumn 44, Issue 2, 2004, Pages 231-234

  Veldman, B A J ^a   Waanders, M ^a   Smits, P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Diabetes; Endothelium; L NMMA; Nitric oxide; Vasodilation

Indexed keywords

N(G) METHYLARGININE; NITRIC OXIDE;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DISEASE COURSE; DRUG MEGADOSE; EARLY DIAGNOSIS; ENDOTHELIUM LESION; FEMALE; FOREARM BLOOD FLOW; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; OPTIMAL DRUG DOSE; OXIDATIVE STRESS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VASOCONSTRICTION; VEIN OCCLUSION; VEIN OCCLUSION PLETHYSMOGRAPHY;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION; FEMALE; FOREARM; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; OMEGA-N-METHYLARGININE; PLETHYSMOGRAPHY; REGIONAL BLOOD FLOW; TIME FACTORS;

EID: 3242809737     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200408000-00013     Document Type: Article

References (24)

1. Calver A, Collier J, Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest. 1992;90:2548-2554.
2. Skyrme-Jones RA, O'Brien RC, Meredith IT. Vasodilator prostanoids, but not nitric oxide, may account for skeletal muscle hyperaemia in Type I diabetes mellitus. Clin Sci (Lond). 2000;99:383-392.
3. Vervoort G, Wetzels JF, Lutterman JA, et al. Elevated skeletal muscle blood flow in noncomplicated type 1 diabetes mellitus: role of nitric oxide and sympathetic tone. Hypertension. 1999;34:1080-1085.
4. Huvers FC, de Leeuw PW, Houben AJ, et al. Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions. Diabetes. 1999;48:1300-1307.
5. Veelken R, Hilgers KF, Harmer A, et al. Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy, J Am Soc Nephrol. 2000;11:71-79.
6. Rongen GA, Smits P, Thien T. NG-monomethyl-L-ARG reduces the forearm vasodilator response to acetylcholine but not to methacholine in humans. J Cardiovasc Pharmacol. 1993;22:884-888.
7. Rongen GA, Smits P, Thien T. Endothelium and the regulation of vascular tone with emphasis on the role of nitric oxide. Physiology, pathophysiology and clinical implications. Neth J Med. 1994;44:26-35.
8. Williams SB, Cusco JA, Roddy MA, et al. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol. 1996;27:567-574.
9. Skyrme-Jones RA, O'Brien RC, Meredith IT. Vasodilator prostanoids, but not nitric oxide, may account for skeletal muscle hyperaemia in Type I diabetes mellitus. Clin Sci (Lond). 2000;99:383-392.
10. Makimattila S, Virkamaki A, Groop PH, et al. Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus. Circulation. 1996;94:1276-1282.
11. Skyrme-Jones RA, Berry KL, O'Brien RC, et al. Basal and exercise-induced skeletal muscle blood flow is augmented in type 1 diabetes mellitus. Clin Sci (Lond). 2000;98:111-120.
12. Johnstone MT, Creager SJ, Scales KM, et al. Impaired endothelium- dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 1993;88:2510-2516.
13. Makimattila S, Virkamaki A, Groop PH, et al. Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus. Circulation. 1996;94:1276-1282.
14. O'Driscoll G, Green D, Rankin J, et al. Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus. J Clin Invest. 1997;100:678-684.
15. Timimi FK, Ting HH, Haley EA, et al. Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol. 1998;31:552-557.
16. Avogaro A, Calo L, Piarulli F, et al. Effect of acute ketosis on the endothelial function of type 1 diabetic patients: the role of nitric oxide. Diabetes, 1999;48:391-397.
17. Cardillo C, Kilcoyne CM, Nambi SS, et al. Vasodilator response to systemic but not to local hyperinsulinemia in the human forearm. Hypertension. 1998;32:740-745.
18. Cockcroft JR, Chowienczyk PJ, Brett SE, et al. Effect of NG-monomethyl-L-arginine on kinin-induced vasodilation in the human forearm. Br J Clin Pharmacol. 1994;38:307-310.
19. Chowienczyk PJ, Cockcroft JR, Ritter JM. Differential inhibition by NG-monomethyl-L-arginine of vasodilator effects of acetylcholine and methacholine in human forearm vasculature. Br J Pharmacol. 1993;110: 736-738.
20. Majmudar NG, Robson SC, Ford GA. Effects of the menopause, gender, and estrogen replacement therapy on vascular nitric oxide activity. J Clin Endocrinol Metab. 2000;85:1577-1583.
21. Brown NJ, Gainer JV, Murphey LJ, et al. Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B(2) receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway. Circulation. 2000;102:2190-2196.
22. McAllister AS, Atkinson AB, Johnston GD, et al, Basal nitric oxide production is impaired in offspring of patients with essential hypertension. Clin Sci (Lond). 1999;97:141-147.
23. Dawes M, Chowienczyk PJ, Ritter JM. Effects of inhibition of the L-arginine/nitric oxide pathway on vasodilation caused by beta-adrenergic agonists in human forearm. Circulation. 1997;95:2293-2297.
24. Cohen RA, Plane F, Najibi S, et al. Nitric oxide is the mediator of both endothelium-dependent relaxation and hyperpolarization of the rabbit carotid artery. Proc Natl Acad Sci U S A. 1997;94:4193-4198.